New insights into food protein-induced enterocolitis in children.


Journal

Minerva pediatrica
ISSN: 1827-1715
Titre abrégé: Minerva Pediatr
Pays: Italy
ID NLM: 0400740

Informations de publication

Date de publication:
Oct 2020
Historique:
pubmed: 21 7 2020
medline: 6 10 2021
entrez: 21 7 2020
Statut: ppublish

Résumé

Food protein-induced enterocolitis syndrome (FPIES) represents a non-IgE-mediated food allergic disorder with delayed gastrointestinal symptoms that may evolve in a medical emergency. Clinically, FPIES can be distinguished into acute and chronic phenotypes. FPIES is mainly diagnosed in infancy however the onset at older ages is being progressively described. The pathogenetic mechanism underlying FPIES remains mainly unexplained, but an alteration of food-specific T-cell response has been proposed. The diagnosis of FPIES is primarily clinical, since there are not available specific biomarkers. Oral food challenge (OFC) is the gold standard for diagnosing FPIES or excluding the onset of tolerance to the triggering food. Management of FPIES includes an acute phase treatment and a maintenance therapy with the strict food avoidance until challenge, in order to prevent new attacks and avoid nutritional alterations. Acute management requires hydration that can be performed orally or intravenously according to clinical status. Long-term management of FPIES is based on the avoidance of the culprit food(s) and supervised introduction of other high-risk foods if never taken before among infants before 12 months of age. There is a compelling need of future achievements in FPIES research for the definition of underlying disease pathogenesis and potential therapeutic point of care.

Identifiants

pubmed: 32686925
pii: S0026-4946.20.05976-9
doi: 10.23736/S0026-4946.20.05976-9
doi:

Substances chimiques

Dietary Proteins 0
Soybean Proteins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

416-423

Auteurs

Carla Mastrorilli (C)

Unit of Pediatric Allergy and Pulmonology, Department of Pediatrics and Emergency, Consorziale-Policlinico University Hospital, Pediatric Hospital Giovanni XXIII, Bari, Italy - carla.mastrorilli@icloud.com.

Angelica Santoro (A)

Department of Medicine and Surgery, Pediatric Clinic, University of Parma, Parma, Italy.

Michela Procaccianti (M)

Department of Medicine and Surgery, Pediatric Clinic, University of Parma, Parma, Italy.

Giuseppe Pagliaro (G)

Pediatric Unit, Department of Obstetrics, Gynecology and Pediatrics, Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, Italy.

Carlo Caffarelli (C)

Department of Medicine and Surgery, Pediatric Clinic, University of Parma, Parma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH